Tags: flu | vaccine | MRNA | Moderna | COVID

Moderna's MRNA-Based Flu Vaccine Shows Promise in Early-Stage Study

vial labeled Moderna and a syringe
(Dreamstime)

Friday, 10 December 2021 09:02 AM EST

Moderna Inc.'s messenger RNA-based experimental seasonal flu vaccine has produced robust antibodies against all four strains of the influenza virus in an early stage study, the vaccine maker said on Friday.

The early-stage study is ongoing and a mid-stage study testing of the vaccine, mRNA-1010, is now fully enrolled, the company said.

This data, though limited, puts Moderna ahead of other drugmakers, including rival Pfizer Inc, that are also testing their flu vaccine based on messenger RNA.

Moderna also said it was developing a pan-respiratory annual booster vaccine, which would target multiple viruses including COVID-19, flu and respiratory syncytial virus.

The new vaccine, mRNA-1345, has demonstrated positive early-stage results, it said.

"Even before the COVID-19 pandemic, approximately three million people died each year due to respiratory infections ... our goal is to limit this suffering with an annual pan-respiratory single dose booster vaccine," Chief Executive Officer Stéphane Bancel said. 

© 2024 Thomson/Reuters. All rights reserved.


Health-News
Moderna Inc.'s messenger RNA-based experimental seasonal flu vaccine has produced robust antibodies against all four strains of the influenza virus in an early stage study, the vaccine maker said on Friday. The early-stage study is ongoing and a mid-stage study testing of...
flu, vaccine, MRNA, Moderna, COVID
149
2021-02-10
Friday, 10 December 2021 09:02 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved